Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis

Hongde Li, Sufang Liu, Jianmin Hu, Xiangjian Luo, Namei Li, Ann M. Bode, Ya Cao

Research output: Contribution to journalReview articlepeer-review

77 Scopus citations


Epstein-Barr virus (EBV) has been associated with several types of human cancers. In the host, EBV can establish two alternative modes of life cycle, known as latent or lytic and the switch from latency to the lytic cycle is known as EBV reactivation. Although EBV in cancer cells is found mostly in latency, a small number of lytically-infected cells promote carcinogenesis through the release of growth factors and oncogenic cytokines. This review focuses on the mechanisms by which EBV reactivation is controlled by cellular and viral factors, and discusses how EBV lytic infection contributes to human malignancies.

Original languageEnglish (US)
Pages (from-to)1309-1318
Number of pages10
JournalInternational Journal of Biological Sciences
Issue number11
StatePublished - Oct 18 2016

Bibliographical note

Funding Information:
This work was supported by the National Natural Science Foundation of China)(nos. 81161120410 and 81101474), the Innovation Foundation of Central South University (no.2013zzts072), and the Collaborative Innovation Center for Chemistry and Molecular Medicine of Hunan province, China.

Publisher Copyright:
© Ivyspring International Publisher.


  • Carcinogenesis
  • Epstein-Barr virus
  • Latency
  • Reactivation
  • Rta
  • Zta


Dive into the research topics of 'Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis'. Together they form a unique fingerprint.

Cite this